Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA

NCT02205489

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Investigational Site Number 056002 Bruges, Belgium
  • Investigational Site Number 056001 Brussels, Belgium
  • Investigational Site Number 250009 Dijon, France
  • Investigational Site Number 250005 Lille, France
View all 20 locations
View Trial Details
Completed

Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)

NCT02159573

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Cullman, Alabama, United States
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
View all 43 locations
View Trial Details
Completed

A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720

NCT01578330

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Ankara, Turkey, Turkey (Türkiye)
  • Novartis Investigative Site Ankara, Turkey, Turkey (Türkiye)
  • Novartis Investigative Site Bursa, Turkey, Turkey (Türkiye)
  • Novartis Investigative Site Izmir, Turkey, Turkey (Türkiye)
View Trial Details
Completed

Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse

NCT01986998

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Hospital Universitari Germans Trias I Pujol de Badalona, Barcelona, Spain
  • Hospital Del Mar Barcelona, Spain
  • Hospital de Mataró Barcelona, Spain
  • Hospital Clinic I Provincial de Barcelona Barcelona, Spain
View Trial Details
Completed

Natalizumab Temporary Discontinuation Study

NCT02775110

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Buffalo Neuroimaging Analysis Center Buffalo, New York, United States
  • Jacobs Neurological Institute Buffalo, New York, United States
View Trial Details

Related conditions